Using AI to improve glaucoma screening in community health centers
RFA-DP-24-081 Implementing AI-based Glaucoma Screening within Federally Qualified Health Centers
This study is testing a new way to use artificial intelligence to help find glaucoma earlier in people who might not have easy access to eye care, especially in communities with a lot of Black residents, where glaucoma is more common.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11023851 on NIH RePORTER |
What this research studies
This research investigates a new approach to screening for primary open angle glaucoma (POAG) using artificial intelligence within Federally Qualified Health Centers (FQHCs). The study aims to implement a validated AI algorithm that interprets ocular imaging and clinical data to enhance early detection of glaucoma, particularly in underserved populations. By focusing on areas with high Black populations, where the prevalence of POAG is significantly higher, the research seeks to provide accessible and effective eye care. The program will be evaluated for its feasibility and effectiveness in improving screening rates and outcomes for at-risk patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in medically underserved areas, particularly those at higher risk for glaucoma, such as Black patients.
Not a fit: Patients who do not reside in areas served by Federally Qualified Health Centers or who are not at risk for glaucoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment of glaucoma, significantly improving eye health outcomes for millions of individuals.
How similar studies have performed: Previous research has shown success in using AI for glaucoma detection, indicating a promising approach for this implementation study.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Owsley, Cynthia — University of Alabama at Birmingham
- Study coordinator: Owsley, Cynthia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.